한글목차

HIV 진단의 동향과 예측

세계의 HIV 진단 시장은 2024년부터 2030년까지의 복합 연간 성장률(CAGR) 10.1%를 나타낼 전망이며 2030년까지 예상 76억 달러에 이를 것으로 예상됩니다. 이 시장의 주요 촉진요인은 헌혈, 수혈수 증가, 포인트 오브 케어 기기, 소모품에 의한 이점, HIV 관련 정부 이니셔티브 증가입니다. 세계의 HIV 진단 시장의 미래는 진단 실험실와 병원 시장에서의 기회에 의해 유망시되고 있습니다.

HIV 진단 시장 인사이트

Lucintel은 항체 검사가 예측 기간 동안 가장 높은 성장을 이룰 것으로 예측됩니다.

북미는 의료 인프라 성장과 HIV 감염률이 높아 효율적인 의료 서비스의 필요성이 높아지기 때문에 예측 기간 동안도 최대의 지역으로 계속 될 것으로 보입니다.

FAQ

Q1. 시장 규모는?

A1. 세계의 HIV 진단 시장은 2030년까지 예상 76억 달러에 이를 것으로 예상됩니다.

Q2. 시장의 성장 예측은?

A2. 세계의 HIV 진단 시장은 2024년부터 2030년까지 복합 연간 성장률(CAGR) 10.1%로 성장할 것으로 예측됩니다.

Q3. 시장 성장에 영향을 미치는 주요 촉진요인은?

A3. 이 시장의 주요 촉진요인은 헌혈, 수혈수 증가, 포인트 오브 케어 기기, 소모품에 의한 이점, HIV 관련 정부 이니셔티브 증가입니다.

Q4. 시장의 주요 부문은?

A4. 세계의 HIV 진단 시장의 미래는 진단 실험실와 병원 시장의 기회에 의해 유망합니다.

Q5. 시장의 주요 기업은?

A5.HIV 진단 주요 기업은 다음과 같습니다.

• Siemens Healthineers
• F. Hoffmann-La Roche
• Abbott Laboratories
• Danaher
• Thermo-Fisher Scientific

Q6. 앞으로 가장 큰 시장 부문은?

A6.Lucintel은 항체 검사가 예측 기간 동안 가장 높은 성장을 이룰 것으로 예측됩니다.

Q7. 시장에서 향후 5년간 최대가 될 것으로 예상되는 지역은?

A7. 북미는 의료 인프라의 성장과 HIV 감염률이 높아 효율적인 의료 서비스의 필요성이 높아지기 때문에 예측기간 동안에도 최대의 지역으로 남아 있습니다.

Q8. 보고서의 커스터마이즈는 가능?

A8. 그렇습니다, Lucintel는 추가 비용 없이 10% 주문을 받아서 만듭니다.

목차

제1장 주요 요약

제2장 세계의 HIV 진단 시장 : 시장 역학

• 소개, 배경, 분류
• 공급망
• 업계의 촉진요인과 과제

제3장 시장 동향과 예측 분석(2018-2030년)

• 거시경제 동향(2018년-2023년)과 예측(2024년-2030년)
• 세계의 HIV 진단 시장 동향(2018년-2023년)과 예측(2024년-2030년)
• 제품별 세계의 HIV 진단 시장
  • 소모품
  • 기기
  • 소프트웨어 및 서비스
• 검사 유형별 세계의 HIV 진단 시장
  • 항체 검사
  • 바이러스량 검사
  • CD4 테스트
  • 기타
• 최종 용도별 세계의 HIV 진단 시장
  • 진단 실험실
  • 병원
  • 기타

제4장 지역별 시장 동향과 예측 분석(2018년-2023년)

• 지역별 세계의 HIV 진단 시장
• 북미의 HIV 진단 시장
• 유럽의 HIV 진단 시장
• 아시아태평양의 HIV 진단 시장
• 기타 지역의 HIV 진단 시장

제5장 경쟁 분석

• 제품 포트폴리오 분석
• 운영상의 통합
• Porter's Five Forces 분석

제6장 성장 기회와 전략적 분석

• 성장 기회 분석
  • 제품별 세계의 HIV 진단 시장의 성장 기회
  • 검사 유형별 세계의 HIV 진단 시장의 성장 기회
  • 최종 용도별 세계의 HIV 진단 시장의 성장 기회
  • 지역별 세계의 HIV 진단 시장의 성장 기회
• 세계의 HIV 진단 시장의 새로운 동향
• 전략적 분석
  • 신제품 개발
  • 세계의 HIV 진단 시장의 능력 확대
  • 세계의 HIV 진단 시장의 합병, 인수, 합작 사업
  • 인증 및 라이선싱

제7장 유력 기업의 기업 프로파일

• Siemens Healthineers
• F. Hoffmann-La Roche
• Abbott Laboratories
• Danaher
• Thermo-Fisher Scientific

영문목차

HIV Diagnostic Trends and Forecast

The future of the global HIV diagnostic market looks promising with opportunities in the diagnostic laboratories and hospital markets. The global HIV diagnostic market is expected to reach an estimated $7.6 billion by 2030 with a CAGR of 10.1% from 2024 to 2030. The major drivers for this market are growing number of blood donations and transfusions, advantages provided by point-of-care equipment & supplies, and increasing HIV-related government initiatives.

A more than 150-page report is developed to help in your business decisions.

HIV Diagnostic by Segment

The study includes a forecast for the global HIV diagnostic by product, test type, end use, and region.

HIV Diagnostic Market by Product [Shipment Analysis by Value from 2018 to 2030]:

• Consumables
• Instruments
• Software & Services

HIV Diagnostic Market by Test Type [Shipment Analysis by Value from 2018 to 2030]:

• Antibody Tests
• Viral Load Tests
• CD4 Tests
• Others

HIV Diagnostic Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

• Diagnostic Laboratories
• Hospitals
• Others

HIV Diagnostic Market by Region [Shipment Analysis by Value from 2018 to 2030]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

List of HIV Diagnostic Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies HIV diagnostic companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the HIV diagnostic companies profiled in this report include-

• Siemens Healthineers
• F. Hoffmann-La Roche
• Abbott Laboratories
• Danaher
• Thermo-Fisher Scientific

HIV Diagnostic Market Insights

Lucintel forecasts that antibody test is expected to witness the highest growth over the forecast period.

North America will remain the largest region over the forecast period due to growing healthcare infrastructure and the high prevalence of HIV infection that have resulted in a greater need for efficient healthcare services.

Features of the Global HIV Diagnostic Market

Market Size Estimates: HIV Diagnostic market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: HIV Diagnostic market size by product, test type, end use, and region in terms of value ($B).

Regional Analysis: HIV Diagnostic market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different product, test type, end use, and regions for the HIV diagnostic market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the HIV diagnostic market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q1. What is the HIV diagnostic market size?

Answer: The global HIV diagnostic market is expected to reach an estimated $7.6 billion by 2030.

Q2. What is the growth forecast for HIV diagnostic market?

Answer: The global HIV diagnostic market is expected to grow with a CAGR of 10.1% from 2024 to 2030.

Q3. What are the major drivers influencing the growth of the HIV diagnostic market?

Answer: The major drivers for this market are growing number of blood donations and transfusions, advantages provided by point-of-care equipment & supplies, and increasing HIV-related government initiatives.

Q4. What are the major segments for HIV diagnostic market?

Answer: The future of the global HIV diagnostic market looks promising with opportunities in the diagnostic laboratories and hospital markets.

Q5. Who are the key HIV diagnostic market companies?

Answer: Some of the key HIV diagnostic companies are as follows.

• Siemens Healthineers
• F. Hoffmann-La Roche
• Abbott Laboratories
• Danaher
• Thermo-Fisher Scientific

Q6. Which HIV diagnostic market segment will be the largest in future?

Answer: Lucintel forecasts that antibody test is expected to witness the highest growth over the forecast period.

Q7. In HIV diagnostic market, which region is expected to be the largest in next 5 years?

Answer: North America will remain the largest region over the forecast period due to growing healthcare infrastructure and the high prevalence of HIV infection that have resulted in a greater need for efficient healthcare services.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the HIV diagnostic market by product (consumables, instruments, and software & services), test type (antibody tests, viral load tests, CD4 tests, and others), end use (diagnostic laboratories, hospitals, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global HIV Diagnostic Market : Market Dynamics

• 2.1: Introduction, Background, and Classifications
• 2.2: Supply Chain
• 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

• 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
• 3.2. Global HIV Diagnostic Market Trends (2018-2023) and Forecast (2024-2030)
• 3.3: Global HIV Diagnostic Market by Product
  • 3.3.1: Consumables
  • 3.3.2: Instruments
  • 3.3.3: Software & Services
• 3.4: Global HIV Diagnostic Market by Test Type
  • 3.4.1: Antibody Tests
  • 3.4.2: Viral Load Tests
  • 3.4.3: CD4 Tests
  • 3.4.4: Others
• 3.5: Global HIV Diagnostic Market by End Use
  • 3.5.1: Diagnostic Laboratories
  • 3.5.2: Hospitals
  • 3.5.3: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

• 4.1: Global HIV Diagnostic Market by Region
• 4.2: North American HIV Diagnostic Market
  • 4.2.1: North American HIV Diagnostics Market by Test Type: Antibody Tests, Viral Load Tests, CD4 Tests, and Others
  • 4.2.2: North American HIV Diagnostics Market by End Use: Diagnostic Laboratories, Hospitals, and Others
• 4.3: European HIV Diagnostic Market
  • 4.3.1: European HIV Diagnostics Market by Test Type: Antibody Tests, Viral Load Tests, CD4 Tests, and Others
  • 4.3.2: European HIV Diagnostics Market by End Use: Diagnostic Laboratories, Hospitals, and Others
• 4.4: APAC HIV Diagnostic Market
  • 4.4.1: APAC HIV Diagnostics Market by Test Type: Antibody Tests, Viral Load Tests, CD4 Tests, and Others
  • 4.4.2: APAC HIV Diagnostics Market by End Use: Diagnostic Laboratories, Hospitals, and Others
• 4.5: ROW HIV Diagnostic Market
  • 4.5.1: ROW HIV Diagnostics Market by Test Type: Antibody Tests, Viral Load Tests, CD4 Tests, and Others
  • 4.5.2: ROW HIV Diagnostics Market by End Use: Diagnostic Laboratories, Hospitals, and Others

5. Competitor Analysis

• 5.1: Product Portfolio Analysis
• 5.2: Operational Integration
• 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

• 6.1: Growth Opportunity Analysis
  • 6.1.1: Growth Opportunities for the Global HIV Diagnostic Market by Product
  • 6.1.2: Growth Opportunities for the Global HIV Diagnostic Market by Test Type
  • 6.1.3: Growth Opportunities for the Global HIV Diagnostic Market by End Use
  • 6.1.4: Growth Opportunities for the Global HIV Diagnostics Market by Region
• 6.2: Emerging Trends in the Global HIV Diagnostic Market
• 6.3: Strategic Analysis
  • 6.3.1: New Product Development
  • 6.3.2: Capacity Expansion of the Global HIV Diagnostic Market
  • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global HIV Diagnostic Market
  • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

• 7.1: Siemens Healthineers
• 7.2: F. Hoffmann-La Roche
• 7.3: Abbott Laboratories
• 7.4: Danaher
• 7.5: Thermo-Fisher Scientific